Cargando…
Neurobiology of rapid acting antidepressants: convergent effects on GluA1-synaptic function
Efforts to develop efficacious antidepressant agents with novel mechanisms have largely unsuccessful since the 1950’s until the discovery of ketamine, an NMDA receptor antagonist that produces rapid and sustained antidepressant actions even in treatment resistant patients. This finding has ushered a...
Autores principales: | Duman, Ronald S., Shinohara, Ryota, Fogaça, Manoela V., Hare, Brendan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754322/ https://www.ncbi.nlm.nih.gov/pubmed/30894661 http://dx.doi.org/10.1038/s41380-019-0400-x |
Ejemplares similares
-
Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms
por: Hare, Brendan D., et al.
Publicado: (2017) -
Roles of the AMPA receptor subunit GluA1 but not GluA2 in synaptic potentiation and activation of ERK in the anterior cingulate cortex
por: Toyoda, Hiroki, et al.
Publicado: (2009) -
Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses
por: Fogaça, Manoela V., et al.
Publicado: (2020) -
Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects
por: Hare, Brendan D., et al.
Publicado: (2019) -
Synaptic plasticity through activation of GluA3-containing AMPA-receptors
por: Renner, Maria C, et al.
Publicado: (2017)